English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/230279
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Amino acid substitutions associated with treatment failure for Hepatitis C virus infection

AuthorsSoria, María Eugenia; García-Crespo, Carlos; Martínez-González, Brenda; Vázquez-Sirvent, Lucía; Lobo-Vega, Rebeca; Ávila, Ana Isabel de; Gallego, Isabel ; Chen, Qian; García-Cehic, Damir; Llorens-Revull, Meritxell; Briones, Carlos ; Gómez, Jordi; Ferrer-Orta, Cristina ; Verdaguer, Núria ; Gregori, Josep; Rodríguez-Frías, Francisco; Buti, María; Esteban, Juan Ignacio; Domingo, Esteban ; Quer, Josep; Perales, Celia
KeywordsNext-generation sequencing
Viral quasispecies
Viral fitness
Antiviral Agents
Viral diagnostics
Treatment planning
Next-generation sequencing
Issue DateDec-2020
PublisherAmerican Society for Microbiology
CitationJournal of Clinical Microbiology 58(12): e01985-20 (2020)
AbstractDespite the high virological response rates achieved with current directly acting antiviral agents (DAAs) against hepatitis C virus (HCV), around 2% to 5% of treated patients do not achieve a sustained viral response. The identification of amino acid substitutions associated with treatment failure requires analytical designs, such as subtype-specific ultradeep sequencing (UDS) methods, for HCV characterization and patient management. Using this procedure, we have identified six highly represented amino acid substitutions (HRSs) in NS5A and NS5B of HCV, which are not bona fide resistance-associated substitutions (RAS), from 220 patients who failed therapy. They were present frequently in basal and posttreatment virus of patients who failed different DAA-based therapies. Contrary to several RAS, HRSs belong to the acceptable subset of substitutions according to the PAM250 replacement matrix. Their mutant frequency, measured by the number of deep sequencing reads within the HCV quasispecies that encode the relevant substitutions, ranged between 90% and 100% in most cases. They also have limited predicted disruptive effects on the three-dimensional structures of the proteins harboring them. Possible mechanisms of HRS origin and dominance, as well as their potential predictive value for treatment response, are discussed.
Publisher version (URL)http://dx.doi.org/10.1128/JCM.01985-20
URIhttp://hdl.handle.net/10261/230279
DOIhttp://dx.doi.org/10.1128/JCM.01985-20
ISSN0095-1137
E-ISSN1098-660X
Appears in Collections:(CBM) Artículos
(IPBLN) Artículos
(CAB) Artículos
(IBMB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.